Immunocytochemically stained vasopressin binding sites on blood vessels in the rat brain.
Following two weeks of cerebroventricular administration of arginine-vasopressin (AVP) by Accurel implants, two types of binding sites for this peptide were immunocytochemically visualized in blood vessels in the brain of Brattleboro (di/di) rats: (1) endothelial cells of capillaries were stained with the highest density in hippocampus, striatum, and locus coeruleus (LC), whereas only few such stained cells were present in the septum and cerebral cortex. (2) Bound AVP was also present on endothelial cells and pericyte-like cells in larger blood vessels in striatum and the LC. Both types of vasopressin binding site staining on blood vessels were dose-dependent and could be further enhanced by additional in vitro preincubation of the fixed sections with AVP. This staining was not present in rats implanted with either oxytocin or alpha-melanocyte-stimulating hormone.
van Zwieten
E J
EJ
Netherlands Institute for Brain Research, Amsterdam.
Ravid
R
R
Swaab
D F
DF
Van de Woude
T
T
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism*; D001921:Brain / Q000098:blood supply* / Q000378:metabolism; D002560:Cerebrovascular Circulation; D004343:Drug Implants; D006624:Hippocampus / Q000098:blood supply / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D010121:Oxytocin / Q000378:metabolism; D051381:Rats; D011910:Rats, Brattleboro; D011945:Receptors, Angiotensin / Q000378:metabolism*; D017483:Receptors, Vasopressin; D000521:alpha-MSH / Q000378:metabolism
D004343:Drug Implants; D011945:Receptors, Angiotensin; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; D010121:Oxytocin; D000521:alpha-MSH